Biotest
Sabine Quast is a highly experienced professional in the field of quality assurance and clinical practices, currently serving as Senior Audit Manager for Corporate Quality Assurance (GCP/GVP) at Biotest AG since March 2019. Prior experience includes roles as a GCP Inspector at Bundesinstitut für Arzneimittel und Medizinprodukte and Team Lead for QA (GMP and GCP) at Boehringer Ingelheim, where focus was on development and GCP in laboratories. Earlier positions included Quality Assurance Manager at Antisense Pharma, Scientist and Quality Management Representative at ID-Labor GmbH, and Scientist in DNA sequencing at MWG Biotech AG. Sabine Quast began a scientific career as a research assistant in the Clinical Chemistry Central Laboratory at the Universitäts des Saarlandes. Educational qualifications include a Diplom in Biology and a Diplom in Human Genetics, both from Universität des Saarlandes.
This person is not in any teams
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.